Preclinical study of MEK1/2 inhibitor AZD6244 combined with gemcitabine for treatment of biliary cancer.
Junyao Xu
No relevant relationships to disclose
Jennifer J. Knox
No relevant relationships to disclose
Ming Sound Tsao
No relevant relationships to disclose
Eric Xueyu Chen
No relevant relationships to disclose
Pinjiang Cao
No relevant relationships to disclose
Chow Sue
No relevant relationships to disclose
Stefano Serra
No relevant relationships to disclose
David W Hedley
No relevant relationships to disclose